Navigation Links
Researcher awarded $1.8 million grant to study gender differences in antidepressant effects
Date:8/15/2013

TALLAHASSEE, Fla. In low doses, the general anesthetic drug ketamine works as an antidepressant, and for females the boost in mood is easier to achieve.

A Florida State University College of Medicine researcher is learning more about why this drug, used as an antidepressant for the last decade, requires a higher dosage to improve depression in males.

Mohamed Kabbaj, a professor in the Department of Biomedical Sciences at the College of Medicine, received a $1.8 million grant from the National Institute of Mental Health to support his research.

"The first purpose is to show the molecular mechanism behind the hormones estrogen and progesterone that are enhancing the effect of ketamine in females," Kabbaj said. "The other purpose of the grant is to determine whether males will respond to estrogen and progesterone in addition to ketamine administered at a low dose."

Researchers are interested in looking for ways around giving higher doses of ketamine to males because of the drug's side effects.

"At medium and high doses, ketamine can create dissociation from one's surroundings," Kabbaj said. "It's also an addictive drug, and you cannot give it chronically."

Administering ketamine with a combination of estrogen and progesterone, which are more abundant in females, may diminish some of these side effects. Kabbaj and his team continue investigating ketamine despite its side effects because of its quick antidepressant response time.

"Ketamine is used as an antidepressant in clinics now because it takes effect acutely," Kabbaj said. "Two hours after one low dose, patients feel better. The classic antidepressants take two to three weeks to work."

This quick, low-dose effect can be a lifesaver for suicidal patients whose repeated thoughts of harming themselves make time a precious commodity. It is also used as an alternative to electroconvulsive shock therapy, which depressive patients sometimes refuse.

But Kabbaj's research has shown that gender differences must be considered.

"Even with classic antidepressants there are studies showing that men and women respond differently to different classes of antidepressant drugs," Kabbaj said. "Their brains are different, so we need to find out if there are treatments that work better in women and treatments that work better in men."

Kabbaj wants to know whether striking the right balance between ketamine, progesterone and estrogen in both genders will allow for safer use of ketamine as an ongoing treatment for depression, so that it can treat those in need of immediate relief from depression without the secondary effects.


'/>"/>

Contact: Julie Jordan
julie.jordan@med.fsu.edu
850-645-9699
Florida State University
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Stress contributes to cognitive declines in women with breast cancer, researcher says
9. Researchers Map Brain Regions Linked to Intelligence
10. Researchers ID Genes That May Determine Mental Illness
11. Researchers Develop Blood Test for Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/13/2017)... ATLANTA , Sept. 13, 2017   OrthoAtlanta ... to the Atlanta Football Host Committee (AFHC) for the 2018 ... Monday, Jan. 8, 2018, at Mercedes-Benz Stadium in ... part of the AFHC "I,m In" campaign, participating in many ... ...
Breaking Medicine Technology: